CANF logo

CANF Can-Fite BioPharma Ltd.

New York Stock Exchange Arca · Biotechnology · Healthcare

$1.44
-0.03 (-2.34%)

Can-Fite BioPharma Ltd. is an Israel-based, clinical-stage biopharmaceutical firm dedicated to developing small molecule therapeutic agents. Its research and development efforts are concentrated on addressing conditions such as cancer, various liver inflammatory diseases, and erectile dysfunction. The company's lead investigational compound, Piclidenoson, has progressed through successful completi…

Market Cap: $1.88Mwww.canfite.com

Price

No data yet.

Social Signal Score

22
5d
10
1 mentions
—
30d
20
4 mentions
—
60d
20
4 mentions
—
90d
37
9 mentions
—
news: 9

Analyst Ratings

4 analysts
Buyconsensus
Strong Buy 0Buy 3Hold 1Sell 0Strong Sell 0
Avg price target$8+457.5%
Low $8Median $8High $8
Current Consensus

Revenue

$101.0K+67.59%
$-1.8K$875.2K$1.75M$2.63M
Sep 2016Jun 2026

Analyst Estimates

FY2025
$-0.52
$-0.52–$-0.52
1 analysts
FY2026
$-2.04
$-2.04–$-2.04
1 analysts
FY2027
$-0.91
$-0.91–$-0.91
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Motti Farbstein
Sector
Healthcare
Industry
Biotechnology
Employees
5
Beta
0.02
Country
IL
Piotroski score
3 / 9 (Weak)
Altman Z-score
-34.15
www.canfite.com